North America Pharmaceutical Logistics Market Size was valued at USD 60.8 Billion in 2022. The North America Pharmaceutical Logistics industry is projected to grow from USD 65.7 Billion in 2023 to USD 121.5 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.00% during the forecast period (2024 - 2032). The necessity for effective supply chain management is one of the major market drivers driving the North America Pharmaceutical Logistics market in North America. North America Pharmaceutical Logistics is being adopted by industries due to its capacity, the rise in the outsourcing of logistical services, and the need for pharmaceutical products.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Pharmaceutical items are in high demand in North America due to the region's expanding population, aging demography, and increased incidence of chronic illnesses. As a result of the growing demand, prompt delivery of medications to patients and healthcare facilities relies on efficient logistics and supply chain management. Logistics companies are taking the lead in implementing renewable energy into their operations to lessen the environmental impact of temperature-controlled biopharma supply chains. Sustainable cold chain strategies are being implemented through the use of bio-based insulation, energy-efficient warehouses, green reefer trucks, solar, wind, or fuel cell-powered facilities, and more. The biopharmaceutical business has grown substantially, fueled by the development of innovative biological medications and treatments. Strong pipeline expansion and new product approvals were caused by the introduction of biologics, such as recombinant proteins, cell and gene treatments, and monoclonal antibodies. This made temperature-controlled logistics more important to preserve product integrity during storage and transit.
Furthermore, to ensure the stability and effectiveness of biopharmaceutical products, cold chain logistics is a crucial component of their distribution. Supply chain visibility, security, and efficiency are being improved by developments in cold chain technologies, such as temperature-controlled packaging, real-time monitoring systems, GPS trackers, IoT integration, and automation. For biologics, advanced freezing methods like cryogenic freezing provide the best preservation. Extended thermal protection is provided by innovative packaging methods, including phase change materials and vacuum-insulated panels (VIPs). Temperature-controlled biopharma distribution entails significant expenses for value-added services, infrastructure, and specialist handling. Regulatory compliance obligations, multi-modal shipping, complex worldwide operations, and an emphasis on reducing product loss all contribute to higher logistics costs. Costs are also affected by seasonal variations in demand and restricted transportation connectivity in some areas. Thus, driving the North America Pharmaceutical Logistics market revenue.
The North America Pharmaceutical Logistics market segmentation, based on Product, includes Generic Drugs and branded Drugs. The branded drugs segment dominated the market. This is because pharmaceutical corporations are the ones who create and market these drugs under their brands. Patents safeguard branded medications, granting the producer the sole authority to create and market the drug for a predetermined amount of time.
Figure 1: North America Pharmaceutical Logistics Market, by Product, 2023 & 2032 (USD Billion)
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The North America Pharmaceutical Logistics market segmentation, based on Mode of Operation, includes Cold Chain Transport and Non-Cold Chain Transport. Cold Chain Transport generated the most income. This is because the term "pharmaceutical cold chain logistics" refers to an intricate, methodical operation in which, before being consumed by consumers, perishable medications and those requiring a low-temperature environment are constantly gathered in an environment with certain temperature ranges at each stage.
The North America Pharmaceutical Logistics market segmentation, based on Application, includes Bio Pharma, Chemical Pharma, and Specialized Pharma. The Chemical Pharma segment dominated the market. This is due in part to biopharma's growing popularity in the pharmaceutical business and its potential to treat illnesses with negligible to no adverse effects. Biopharma logistics will, therefore, be in great demand in the future.
The North America Pharmaceutical Logistics market segmentation, based on Mode of Transport, includes Air Shipping, Rail Shipping, Road Shipping, and Sea Shipping. The Air Shipping segment dominated the market. This is because of its ability to deliver pharmaceutical products efficiently and quickly over long distances. Additionally, air travel offers temperature-controlled conditions for the transfer of temperature-sensitive medicines, which makes it a popular mode of transportation for these goods.
The aging population, improvements in medical technology, and rising rates of chronic illnesses have made the United States one of the countries with the highest healthcare costs in the world. Pharmaceutical products are in greater demand as a result, which calls for effective supply chain management and logistics. The United States' pharmaceutical distribution landscape has changed due to the rise of e-commerce and online pharmacies. The simplicity of obtaining drugs online is becoming more and more appealing to consumers, which increases the demand for dependable and effective pharmaceutical logistics services to fulfill these purchases. In order to improve access to prescription drugs and healthcare services, the United States healthcare system is placing an increasing emphasis on patient-centric care. In order to guarantee the prompt delivery of pharmaceuticals to healthcare facilities, pharmaceutical logistics is essential.
Figure 2: North America Pharmaceutical Logistics Market Share By Region 2023 & 2032 (USD Billion)
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Leading market players are putting a lot of money into R&D to increase the range of products they sell, which will support further growth in the North America Pharmaceutical Logistics market. In addition, market players are engaging in a range of calculated initiatives to increase their presence, with significant market developments involving the introduction of new products, contracts, M&A transactions, increased investment, and cooperation with other enterprises. to grow and endure in an increasingly cutthroat and dynamic market, North America Pharmaceutical Logistics industry must provide reasonably priced goods.
Major players in the North America Pharmaceutical Logistics market are engaging in research and development activities in an effort to boost market demand, including Deutsche Post DHL, FedEx, Kuehne + Nagel International AG, United Parcel Service Inc., C.H. Robinson Worldwide Inc., CEVA Logistics, DB Schenker, Agility Logistics, Air Canada.
In April 2023 when Panalpina, one of the prominent logistics service providers, also received news of its intention to merge with DHL Supply Chain. This strategy is focused on elevating the logistics performance of the pharmaceutical firms, particularly the cold chain logistics of such temperature-sensitive products. By means of the merger, operational efficiency and the logistics network in North America will be improved.
Looking at the July 2023 picture, McKesson Corporation completed the purchase of Change Healthcare. This $13 Billion acquisition targets improvement of healthcare logistics, especially in the distribution of pharmaceutical products. The Partners also intend to improve supply chain visibility and better healthcare by employing Change healthcare within its supply chain.
The month of September 2023 came along with announcements from AmerisourceBergen on their partnership with Celerion, a contract research organization (CRO) for the enhancement of clinical trial supply logistics. This partnership works on switching the supply of drugs to research centers and clinical sites and minimizes the time lost in getting medicines needed for studies. This partnership is likely to enhance their abilities in the management of complex logistics during clinical studies.
In January 2024, Cardinal Health and Genentech signed a merger agreement intending to improve their collaboration in the area of supply chain management. As a result of the merger, a powerful company focusing on logistics and the supply chain of biopharmaceuticals would be created with a special concentration on specialty pharmaceuticals where distribution is the essence of the product​.
Also, Ryder System, Inc. announced plans of acquisition of C3S, a pharmaceutical logistics provider, in February 2024. This acquisition is likely to add more value to Ryder’s portfolio as well as help increase the range of services offered, especially in the area of temperature-controlled logistics essential for the pharmaceutical industry​.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 60.8 Billion |
| Market Size 2023 | USD 65.7 Billion |
| Market Size 2032 | USD 121.5 Billion |
| Compound Annual Growth Rate (CAGR) | 8.00% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product, Mode of Operation, Application, Mode of Transport and Region |
| Region Covered | North America |
| Countries Covered | The US, Canada, Mexico, and the Rest of North America |
| Key Companies Profiled | Deutsche Post DHL, FedEx, Kuehne + Nagel International AG, United Parcel Service Inc., C.H. Robinson Worldwide Inc., CEVA Logistics, DB Schenker, Agility Logistics, Air Canada |
| Key Market Opportunities | ·      the rise in the outsourcing of logistical services |
| Key Market Dynamics | ·      Growing consumer need for pharmaceutical products. ·      Increasing use of the necessity for effective supply chain management, |
Frequently Asked Questions (FAQ) :
The North America Pharmaceutical Logistics market size was valued at USD 65.7 Billion in 2023.
The market is projected to grow at a CAGR of 8.00% during the forecast period, 2024-2032.
The key players in the market are Deutsche Post DHL, FedEx, Kuehne + Nagel International AG, United Parcel Service Inc., C.H. Robinson Worldwide Inc., CEVA Logistics, DB Schenker, Agility Logistics, Air Canada, and others.
The Air Shipping category dominated the market in 2023.
Chemical Pharma had the largest share of the market.
Senior Research Analyst I have a bachelor's degree in mechanical engineering and an mba. i have more than two years of expertise in the retail, food, and beverage, chemical, and material industries, and hence have developed a sound cross-domain expertise. a firm believer in lifelong learning and sharing of knowledge. having a proclivity for hatching ideas and trying to absorb as much information as possible in a short amount of time. introducing corporates to the data and insight, which enables them to move from probability to possibility, has been my key areas of interest.Â
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
